Our data indicate that these MYC-regulated miRNAs are additionally affected by EBV and 1q gains in BL and, in case of hsa-miR-28-5p, a possible regulation independent of EBV and 1q gains. The gene discussed is MYC; the disease is Burkitt lymphoma.